In gastric cancer, deposition of C3 fragments on tumor cells activates the JAK2/STAT3 pathway, increasing levels of phosphorylated STAT3 (promoting cell proliferation and migration) and IL-6 (54). Here, JAK2 is linked to neoplasm.